Your access to use and prescribe compounded hormones is at risk. Take Action Now
The FDA is considering recommendations that would outlaw compounded bioidentical hormones.
Give us your email address: we will keep you informed when there is an action to take and how to take it.
We are a Coalition. We have important partners that are both members of our Coalition, and are doing very great work themselves. Here are links to them:
You can learn about the issues involved
cBHRT & How We Could Lose It
A brief history of cBHRT and update of the FDA's current challenges to its existence
In Depth Information
A Dive into the Science supporting cBHRT and into the Legal and Political responses
What you can do about it..
Join our email list and we will notify you about coordinated actions to take
We will be calling for timely and coordinated:
- Communications to the FDA
- Communications to Congress and the Executive Branch
- National Call-in Day
- Perhaps a March on Washington
Your access to compounded hormones is at risk...but you can take action to protect them.
We could lose cBHRT
A history of cBHRT and update of the FDA's current challenge to its existence
Case Studies
Share and read case studies of women safely and successfully using compounded bioidentical hormone replacement therapies.
Join the effort and protect your patients
Join the effort to ensure that your right to practice medicine without undue government involvement.
JOIN US - GET INVOLVED
OUR MISSION
Prevent the FDA from eliminating the choice for doctor’s to prescribe compounded bioidentical hormones and maintain a choice of therapies.
Doctors and licensed medical professionals must be able to practice medicine based on their education, experience and clinical expertise. Woman should have the option to choose between FDA approved drugs AS WELL as customized, compounded formulations based on their doctor’s recommendation.
Protect CBHT is a non-profit coalition made up of medical professionals who want to protect these rights and maintain the ability to practice medicine without unnecessary and inappropriate government interference.
LATEST NEWS & UPDATES
[Direct relationship to need for individualization]:Conference call with the NASEM Committee on the Clinical Utility of Treating Patients with Compounded Bioidentical Hormone Replacement Therapy and Daved Rosensweet M.D. Dr Rosensweet’s responses to questions from the NASEM Committee on 8/22/19:Questions 2 & 3:
[questions to Dr Rosensweet from the. NAAEM Committee:] “Formulations:In your email, you mention that the customization for
Transdermal cBHRT use is associated with a significantly lower incidence of increased mammographic breast density and breast tenderness compared with oral HRT.
Hormone replacement therapy and breast density changes Climacteric. 2005 Jun;8(2):185-92. J Harvey1, C Scheurer2, FT Kawakami2, E
The importance of not increasing breast density, i.e. breast glandular cell proliferation, in our hormone treatment programs.
Mammographic Density and the Risk and Detection of Breast Cancer Norman F. Boyd, M.D., D.Sc., Helen Guo,
Features
- Yoga Training
- Healthy Eating Habits
- Simple Language
- Lifetime Access
- No Ads. Focus on Health.
Benefits
- Improve Your Stamina
- Get Better Health
- Achieve Peace of Mind
- Look Young & Beautiful
- Achieve more in Life
Featured In
Trusted by over 7000 Health Seekers, Worldwide. Since 2005.
Jessica Simon
The Trainers
Jamie Hofstadter
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo luctus .
Annie Hofstadter
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo luctus .
Happy Faces of Happy Students
